Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys12 salesCumulative net flow
Total declarations
20
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€13.0M

Latest filing published 13 Jul 2026 for Dianthus Therapeutics, Inc. /DE/, €497k.

Filing timeline

BuySale
Ryan Savitz

Insider track record

Disclosed buys
0
Disclosed sells
14

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Ryan Savitz: trading record in brief

Ryan Savitz appears in our data through filings on Dianthus Therapeutics, Inc. /DE/ shares, published by SEC (Form 4). We count 20 filings; the first trade dates from 9 September 2025 and the latest from 9 July 2026.

On the market, this insider has only sold: 14 sales, €13.0M in total. Other entries cover 6 option exercises. So far in 2026, the count stands at no purchases and 12 sales.

On 13 July 2026 came the latest disclosure, an option exercise for €595k in Dianthus Therapeutics, Inc. /DE/. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ryan Savitz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations